U.S. Markets closed

Germantown stem cell therapy company proposes $7M offering amid delisting threat

Sara Gilgore
Germantown stem cell therapy company proposes $7M offering amid delisting threat

The company’s future on the Nasdaq hangs in the balance, as its share price continues to sit below a buck in the wake of a delisting threat from the exchange.